About Jennifer

Jennifer Greeby, Senior Vice President, Launch Excellence, leads Precision’s service offering to help clients better integrate data sources and focus the right business questions on patient-centric solutions across the launch continuum. The breadth and depth of Precision’s capabilities affords our unique ability to help clients move fluidly from development to commercialization, leveraging deep analytics and expertise, driving focused access and demand.

Jen has 25+ years of industry experience leading launches in various commercial functions across the entire product life-cycle. Having led both US and Global launches in oncology, rare and orphan disease, diabetes, obesity, renal, gastroenterology and others, Jen brings an acute understanding of and passion for integrating advanced analytics and the voice of customers, across the enterprise, to de-risk success with high specificity and speed to market. Her expertise is the calm clarity she brings to complex commercial challenges working cross-functionally to accelerate transformation.

Before PRECISION, Jen was with Athenex, an emerging oncology biotech, and previously held commercial leadership roles across multiple brands and franchises at Shire/Baxalta, Takeda, TAP and Baxter along with prior sales and marketing experience at Procter & Gamble and Amoco Chemicals.

Jen holds an MBA from the University of Michigan and BSc in engineering from the University of Cincinnati.